RxDoctor Payments Data

Travis James, DO

Dermatology · Providence, UTNPI 1477818920

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $382,416 of the $437,411 with a category attached, or 87.4%. Lilly USA, LLC accounts for 75.9% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $143,430, 2.1 times the $69,425 reported in 2019. Among dermatology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$437,411in general payments, 2019–2025

Across 819 payments — averaging $534.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$332K
  • UCB, Inc.$80K
  • Galderma Laboratories, L.p.$18K
  • E.r. Squibb & Sons, L.L.C.$3K
  • Novartis$2K
  • AbbVie$665
  • plus $2K from 24 others
$34,107in research payments, 2019–2025

Across 4 payments — averaging $8526.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Amgen$34K

What the payments were for

  • Consulting fees$16,8304%
  • Speaking & faculty fees$382,41687%
  • Travel & lodging$27,7116%
  • Food & beverage$9,9492%
  • Education$5050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$437,411 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah

Medicare billing

Part B allowed, 2024
$60,178
Medicare patients
184
Services billed
1,850

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate112$5,767
Triamcinolone Acetonide95$1,239
Metronidazole19$901
Ketoconazole38$463
Doxycycline Hyclate24$456
ValacyclovirValacyclovir Hcl12$332
MethotrexateMethotrexate Sodium28$307
Terbinafine Hcl20$259
Nystatin13$207
Hydrocortisone38$181
Prednisone19$135
Mupirocin15$115
Folic Acid11$26

Paid to pharmacies, not to this prescriber.

Other dermatology in Providence

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →